EVENITY® (Romosozumab) is a biologic indicated for treatment of postmenopausal women at high risk for fracture or patients who have failed or are intolerant to other available osteoporosis therapy.

EVENITY® is manufactured by Amgen.

Administration and Dosage:

Administration of EVENITY® is 2 subcutaneous injections once a month for 12 months.

Common Side Effects:

The more common side effects of EVENITY® include serious allergic reactions, low calcium levels in your blood (hypocalcemia), severe jaw bone problems (osteonecrosis), unusual thigh bone fractures, joint pains, and headaches.

More Information:

Please read the full Prescribing Information and Medication Guide for EVENITY® and discuss any questions you have with your doctor.

Ready to Schedule an Appointment?

Please CLICK HERE to get started.


EVENITY® is indicated to treat:

  • Osteoporosis